Get the full Solstice Health company profile
Access contacts, investors, buying signals & more
For life sciences marketing teams grappling with content creation, Solstice Health offers an AI engine designed to accelerate the process. The company has now secured $21.0M in Series A funding, with investment from Transformation Capital, Twelve Below, and Virtue Ventures.
Solstice Health's platform focuses on the creation, evaluation, and distribution of personalized content, enabling pharmaceutical brand teams to rapidly deploy compliant materials at scale.
💰 New York-based Solstice has raised $21 million in a Series A round led byTransformation Capital to accelerate how pharmaceutical companies create and approve compliant marketing content using AI.
Existing investors includingTwelve Below andVirtue Ventures also participated in the round, bringing the company’s total funding to approximately $25 million.More details 👉https://lnkd.in/gAfhP3SgYiwen L.Aris Saxena Vinay Shah Brice Schreter#funding #biotech #ustech #startups #innovation #investment #vcfunding #technology #ai
Kubera Health
Kubera’s mission is to power a payment ecosystem where contracts are honored, care is rewarded, and waste is eliminated. We deliver contract and payment intelligence that unifies policies, terms, and claims data into one trusted platform — helping healthcare organizations and their partners build fairer contracts, ensure payments flow as intended, and align incentives across the care ecosystem. As healthcare shifts toward new reimbursement models and risk-sharing arrangements, Kubera is building the payment-intelligence backbone that enables multiple parties to adapt faster, protect margins, and dedicate more resources to patient care.
$6.5M Seed
today
Psilera
Psilera is a biotechnology company founded by scientists dedicated to finding better therapeutics for neurological conditions like dementia, addiction, and mental health disorders. Since 2019, Psilera has been focused on early-stage drug discovery & development with a dynamic team of experts in synthetic chemistry, pharmacology, clinical development, and business development.
$8.8M Seed
today
Abstract
Abstract is a venture capital firm based in San Francisco with $1.5 billion in assets under management. We are sector-agnostic, focused on seed and early stage founders. Our reputation among founders is built on fierce loyalty, unparalleled connections, and a relentless drive to help them win.
$59.0M Series a
today
Daloopa
Delivering trusted financial data across 5,500+ global tickers that powers AI agents, LLMs, and leading financial institutions worldwide. Analysts at the top investment firms use our workflow solutions to save valuable time and accelerate their decision making. We also provide the core AI data infrastructure that underpins the best financial agents and are the partner of choice for the leading global AI companies, including OpenAI, Anthropic and Perplexity. Get in touch at hello@daloopa.com.
$47.0M Series c
today
Secretome Therapeutics
Revolutionizing cell therapy to address inflammatory diseases driven via neonatal cardiac progenitor cells and their secretomes.
$30.0M Series a
today
Largest funding rounds in AI on Signalbase right now.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 |  Nuance Healthcare United States | Unknown | $19.7B | 1y ago |
| 2 |  Anthropic | Series f | $13.0B | 8mo ago |
| 3 |  OpenAI United States | Unknown | $13.0B | 1y ago |
| 4 |  AIMAX United Kingdom | Unknown | $10.0B | 1y ago |
| 5 |  Preferred Networks, Inc. Japan | Unknown | ¥10.0B | 1y ago |
Companies that recently closed a Series a round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 | Abstract United States | Series a | $59.0M | today |
| 2 |  Pacifico Biolabs | Series a | $7.6M | today |
| 3 | Secretome Therapeutics United States | Series a | $30.0M | today |
| 4 |  Geordie AI United Kingdom | Series a | $30.0M | today |
| 5 |  Lastwall Canada | Series a | $11.5M | today |
